| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714675 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 7 Pages |
Abstract
Careful risk-benefit assessment may enable the continuation of antibiotic therapy despite MPE, provided that patients are under close medical observation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Axel MD, Sandrine MD, Matthias MD, Johanna MD,